CI vs MTNB · P/E 2.4, rev $274.90B vs rev $1.1M
Cigna Corp (CI) versus Matinas BioPharma Holdings Inc (MTNB) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported MTNB revenue for 2023-12-31 was $1.1M. Net income was -$22.9M. Revenue was down 65.6% from 2022-12-31 to 2023-12-31. MTNB currently screens at market cap $5.6M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. MTNB currently screens at market cap $5.6M.
Not investment advice. Open the CI and MTNB stock pages for the full models.
Not investment advice.